Female Fertility: What You Should Know About Age, Ovarian Reserve, and Testing

Casual conversations about female fertility often rely on a shorthand like "fertility crashes after 35," as if there were one sharp cutoff. The reality shown by data from fertility-clinic registries and cohort studies of couples trying to conceive is more gradual: fertility begins declining as early as the late twenties, accelerates in the mid-thirties, and accelerates again noticeably after 40. There isn't one threshold — there's a continuous, if uneven, curve.

This distinction matters in practice. A 32-year-old still has relatively good odds of natural conception compared to a 39-year-old, even though both are technically "in their thirties." Treating fertility as binary — fine up to 35, suddenly a problem after — distorts what is actually a gradual, if unavoidable, biological trend, and can cause both unnecessary anxiety in younger women and unwarranted optimism in women closer to 40.

One of the best-documented sources on the effect of age on fertility is a classic cohort study of couples using natural family planning methods, in which daily sexual activity and the day of ovulation were recorded based on basal body temperature measurements.

A second, complementary data source is the annual reports from the U.S. Centers for Disease Control and Prevention (CDC) on the success of assisted reproductive technology (ART, including IVF). This data captures the ultimate outcome — a live birth — rather than just conception, making it a particularly clear picture of the combined effect of age on the entire reproductive process.

It's worth noting these are ART figures, which by definition concern a population already facing conception difficulties — they shouldn't be read directly as odds of natural conception in an average fertile couple. But the direction and scale of the age-related decline are consistent with Dunson's data and other cohort studies of couples without diagnosed infertility, which is what makes this trend one of the best-established facts in reproductive medicine.

Unlike sperm, which are produced continuously throughout a man's adult life, a woman is born with a fixed, non-renewable supply of egg cells — estimated at around 1-2 million at birth, of which only a fraction remains by puberty. This pool, called the ovarian reserve, declines continuously from birth onward, regardless of whether a woman becomes pregnant, uses hormonal contraception, or has no sexual activity at all — hormonal birth control does not "save" egg cells or slow the natural rate of their depletion.

Age-related fertility decline results from two overlapping phenomena: the shrinking number of remaining eggs (quantity) and the rising proportion of eggs with chromosomal abnormalities (quality) as a woman ages. This second phenomenon explains why, past 35-40, not only does conception become harder, but the risk of miscarriage and chromosomal abnormalities in the fetus (such as trisomy 21) also rises — older eggs that have persisted longer through the meiotic division process more often carry errors in chromosome separation.

Anti-Müllerian hormone (AMH) is currently the most commonly used biomarker of ovarian reserve — it's produced by small, developing ovarian follicles, and its level correlates with the number of remaining follicles. Unlike follicle-stimulating hormone (FSH) and estradiol, AMH can be measured on any day of the cycle, which makes testing logistically convenient. Antral follicle count (AFC), assessed by transvaginal ultrasound, is also used to evaluate ovarian reserve.

In practice, this means an AMH result is best interpreted alongside age, cycle regularity, and the full clinical picture, ideally in conversation with a specialist — not as an isolated number from a private lab. A single borderline result shouldn't be a source of panic without a gynecologist putting it in proper context either.

It's worth noting that none of these modifiable factors can reverse or meaningfully slow the natural, age-related decline in the number and quality of egg cells. Their role is more about not adding avoidable obstacles on top of an ovarian reserve that's already aging — while for couples with otherwise normal baseline fertility, they can genuinely increase the chance of conception in a given month.

Conversations about fertility tend to focus on the woman, yet the male factor accounts for a meaningful share of all conception difficulties — either alone or combined with the female factor. Sperm quality (count, motility, and morphology) also declines with a man's age, though usually more gradually and less dramatically than ovarian reserve in women. For more on what actually affects male fertility, see our article on male fertility.

The American Society for Reproductive Medicine (ASRM) and the American College of Obstetricians and Gynecologists (ACOG) offer fairly precise, age-based guidance on when a couple should consult a fertility specialist rather than continuing to wait for natural conception.

Fertility data tends to get used in two opposite ways: either to spark needless panic in 28-30-year-olds who statistically still have very good odds, or to falsely reassure women closer to 40 that "women have children later these days, so it's not really an issue." A responsible approach treats age as one important factor among several, alongside modifiable lifestyle elements and a realistic assessment of individual health.

The most useful practical takeaway from this data isn't to rush into pregnancy at all costs, but to have a realistic picture of the pace of change and not delay a specialist consultation longer than guidelines suggest — especially since early workup doesn't commit anyone to immediate treatment, it just provides a fuller picture for making an informed decision.